The American Heart Association (AHA) awarded grants to two research scientists in NYC and Baltimore to investigate the link between cardiovascular health and diabetes.
Dr. Ann Marie Schmidt in NYC will study the impact of white blood cells and a protein called RAGE on diabetic conditions, aiming to develop therapeutic strategies.
Her research may elucidate how diabetes affects multiple body systems, leading to complications like heart attacks and strokes, offering new treatment possibilities.
Dr. Elizabeth Selvin in Baltimore will focus on continuous glucose monitoring systems to improve diabetes management and cardiometabolic health.
The research by Selvin could enhance public health policies on diabetes care by providing real-time glucose tracking for better patient outcomes.
Both scientists emphasize mentoring future researchers and fostering collaborative efforts, reflecting a shift towards interdisciplinary research in health science.
The AHA's funding supports groundbreaking research to address the increasing prevalence of diabetes and cardiovascular diseases globally.
The research aims to offer practical solutions to mitigate the impacts of diabetes and heart diseases, benefiting vulnerable populations.
The AHA's investment in research underscores its mission to save lives by translating innovative ideas into actionable health strategies.
Schmidt and Selvin's work may lead to improved clinical practices and better management of diabetes and cardiovascular conditions in diverse populations.